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background: Stent thrombosis (ST) has been described as a rare event in current drug-eluting stent (DES) era; however, its occurrence has been 
associated with relatively high morbimortality. Our objective was to investigate the impact of second generation DES on the occurrence of ST in daily 
clinical practice.
Methods: A total of 4,790 pts (7,530 lesions) undergoing elective for emergency PCI solely with DES as a default strategy were enrolled between 
May/02-Mar/13. Clinical follow-up (FU) was performed at 1, 6 and 12 months and yearly up to 10 years (97.3%). Overall, a total of 8,058 DES were 
implanted including 1st generation (Cypher/Taxus) in 69% and 2nd generation (Xience/Promus/Resolute/Endeavor/BioMatrix) in 31%, given that 
mean FU for pts treated with 1st vs. 2nd generation DES were 5.3±2.6 vs. 1.1±1.0, respectively.
results: Overall, mean age was 64 years, 31% had diabetes, 23% had previous MI and 41% presented with acute coronary syndrome. Compared 
to pts treated with 1st generation DES, those treated with 2nd generation DES had more diabetes (p<0.001), multivessel disease (p<0.001), and 
multiple DES implanted (p<0.001), but angiographic success was similar in both groups (>99%). The occurrence curve for ST (ARC) up to 2 years FU 
with landmark analysis at 1 year is shown in the Figure.
conclusions: Compared to 1st generation DES, 2nd generation DES was associated with a non-significant trend towards less ST up to 2 years FU, 
given that there was no very late ST found with 2nd generation DES.
